More than a third of CMOs are struggling to keep skilled technical and production staff.

Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023

The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market.

Outsourcing Formulation Services for Biologics

The more information shared, the smoother the approval process, says Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates.

Sharing Critical Information for the Best Outcome

Topic

Feliza Mirasol is the science editor for 

Articles

MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.

MilliporeSigma Expands Biologics Testing Center in China

Chris Spivey is the editorial director of 

PharmTech Europe discusses technology that enables the “democratization” of mRNA manufacturing with Scott Ripley, general manager, Nucleic Acid Therapeutics and Precision Nanosystems, Cytiva, at the 11th International mRNA Health Conference in Berlin, Germany.

Democratizing GMP Manufacturing for the New Therapeutic Pipeline

Matthew Hewitt is vice-president, technical officer, Cell & Gene Therapy & Biologics, at Charles River Laboratories.

Larry Bellot, PhD, is scientific advisor, Cell and Gene Therapy, at Charles River Laboratories.

Chad Andersen is associate director, Manufacturing Sciences & Technology, at Charles River Laboratories.

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.

Best Practice Tech Transfer Methods for CGTs

As part of a $30 million investment, Aragen is setting up a new biologics manufacturing facility in Bangalore, India.

Aragen to Establish $30 Million Biomanufacturing Facility in India

Jason Hansell is Junior Applications Technologist at Colorcon Inc. (PA, USA).

Shahrzad Missaghi, PhD, is senior manager—Product Development at Colorcon.

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

The New Digital Era for Formulation Development

Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.

Cellares Expands Agreement with Bristol Myers Squibb for Second CAR-T Program 

Editor of Pharmaceutical Technology Europe

Cambrex has completed the expansion of its North Carolina facility, doubling its manufacturing capacity.

Cambrex Doubles Manufacturing Capacity with Latest Expansion

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

With the acquisition, Sharp plans on offering fully integrated small-to-medium scale sterile injectable services.

Sharp Acquires Berkshire Sterile Manufacturing

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

Doug Nissinoff is director, Research Projects at BioPlan Associates.

Consistent growth in outsourced biomanufacturing points to an evolving industry increasingly reliant on external capacity and expertise.
